JHIU
AEGR

Janus Henderson Investors US’s Aegerion Pharmaceuticals AEGR Stock Holding History

Janus Henderson Investors US’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-449,128
Closed -$20.7M – 1129
2014
Q1 		$20.7M Buy
449,128
+125,932
+39% +$7.39M 0.02% 552
2013
Q4 		$22.9M Buy
323,196
+114,700
+55% +$8.77M 0.02% 520
2013
Q3 		$17.9M Sell
208,496
-84,793
-29% -$7.19M 0.02% 550
2013
Q2 		$18.6M Buy
+293,289
New +$15.6M 0.02% 513

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Investors US's AEGR Position: Q2 2014 in Review

Janus Henderson Investors US sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2014, closing a stake of 449,128 shares — an estimated $20.7M sold.

Janus Henderson Investors US first reported a position in AEGR in Q2 2013 and held it in 4 quarters. The position peaked at $22.9M in Q4 2013. 129 funds tracked by Wall St. Rank hold AEGR as of Q2 2014.

  • Janus Henderson Investors US reported no remaining Aegerion Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Janus Henderson Investors US sold 449,128 Aegerion Pharmaceuticals shares in Q2 2014, an estimated $20.7M.
  • Janus Henderson Investors US first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Janus Henderson Investors US's Aegerion Pharmaceuticals position peaked at $22.9M in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2014.

Based on Janus Henderson Investors US's 13F filing for Q2 2014, filed 14 Aug 2014.